Safety, Tolerability and Clinical Effects of a Rapid Dose Titration of Subcutaneous Treprostinil Therapy in Pulmonary Arterial Hypertension: A Prospective Multi-Centre Trial

URN to cite this document:: urn:nbn:de:bvb:355-epub-376398
DOI to cite this document:: 10.5283/epub.37639

Grüning, Ekkehard ; Benjamin, Nicola ; Lange, Tobias J. ; Krueger, Ulrich ; Klose, Hans ; Neuroher, Claus ; Wilkens, Heinrike ; Halank, Michael ; Seyfarth, Hans-Jürgen ; Held, Matthias ; Traube, Andrew ; Pernow, Michelle ; Grover, E. Robert ; Egenlauf, Benjamin

; Gerhardt, Felix ; Viethen, Thomas ; Rosenkranz, Stephan

License: Allianz- bzw. Nationallizenz
PDF - Published Version
(362kB)

Date of publication of this fulltext: 28 Aug 2018 14:38

Alternative links to fulltext:DOI Publisher

Details

Preview

Indexed in

Export bibliographical data

Abstract

Background: Subcutaneous treprostinil has dose-dependent beneficial effects in patients with severe pulmonary arterial hypertension, but adverse effects like infusion site pain can lead to treatment discontinuation. Objectives: The objective of this study was to evaluate safety, tolerability and clinical effects of a rapid up-titration dosing regimen of subcutaneous treprostinil using proactive ...